All In Biotech

Drug Trial Radar · NCT05201404

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Last checked: Nov 19, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 471 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

471

Planned (sponsor's estimate)

Start

Mar 15, 2023

Primary completion

Feb 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Can-Fite BioPharmaIndustry
Sponsor type
Industry
First posted
Jan 21, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a clinical trial in patients with advanced hepatocellular carcinoma (HCC) and Child-Pugh Class B7 (CPB7) cirrhosis whose disease has progressed on at least 1st-line therapy. The trial will evaluate the efficacy and safety of namodenoson as compared to placebo.

Conditions

  • Hepatocellular Carcinoma
  • Cirrhosis

Interventions

  • NamodenosonDrug

    Adenosine A3 Receptor (A3AR) agonist

  • PlaceboDrug

    Control arm

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Survival (OS)Time frame: From the time of randomization until the date of death from any cause, assessed up to 60 months

Locations

32 sites in 9 countries. Site status is shown where the registry gives one.

  • Site 881

    Dallas, Texas · Not yet recruiting

  • 841 University Clinical Centre of Republic of Srpska

    Banja Luka, Bosnia and Herzegovina · Not yet recruiting

  • 843 University Clinical Hospital Mostar

    Mostar, Bosnia and Herzegovina · Not yet recruiting

  • 842 University Clinical Centre Sarajevo

    Sarajevo, Bosnia and Herzegovina · Not yet recruiting

  • 831 Dept of Medical Oncology, Complex Oncology Ctr - Burgas EOOD

    Burgas, Bulgaria · Not yet recruiting

  • 835 First Department of Medical Oncology, Gastroenterology and Pulmology, Complex Oncology Center - Plovdiv EOOD, Plovdiv

    Plovdiv, Bulgaria · Not yet recruiting

  • Medical Center Leo Clinic EOOD Plovdiv

    Plovdiv, Bulgaria · Not yet recruiting

  • 834 Medical Oncology Dept, Univ Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EAD, Sofia

    Sofia, Bulgaria · Recruiting

  • 518 Rabin Medical Center Beilinson Hospital

    Petah Tikva, Israel · Recruiting

  • 872 IMSP Institute of Oncology

    Chisinau, Moldova · Recruiting

  • Site 858

    Koszalin, Poland · Not yet recruiting

  • Site 852

    Krakow, Poland · Not yet recruiting

  • Site 857

    Mysłowice, Poland · Not yet recruiting

  • Site 859

    Przemyśl, Poland · Not yet recruiting

  • Site 855

    Warsaw, Poland · Not yet recruiting

  • Site 850

    Wroclaw, Poland · Not yet recruiting

  • 802 Institutul Regional de Gastroenterologie si Hepatologie

    Cluj-Napoca, Romania · Recruiting

  • 807 IOCN, Medical Oncology

    Cluj-Napoca, Romania · Not yet recruiting

  • 809 Spitalul Clinic Judetean de Urgenta Constanta Oncology Dept

    Constanța, Romania · Not yet recruiting

  • 801 Oncology Center "Sf. Nectarie" Medical Oncology

    Craiova, Romania · Recruiting

  • 803 Oncolab SRL

    Craiova, Romania · Recruiting

  • 805 Euroclinic lasi

    Iași, Romania · Recruiting

  • 810 IRO Iasi-Clinica Oncologie Medicala

    Iași, Romania · Recruiting

  • 808 Spitalul Clinic Pelican Oradea Oncology Department

    Oradea, Romania · Recruiting

  • 804 Oncomed - Medical Oncology

    Timișoara, Romania · Recruiting

  • 806 Oncocenter Oncologie Clinica SRL

    Timișoara, Romania · Recruiting

  • 821 Clinic for Gastroenterology and Hepatology, Military Medical Academy

    Belgrade, Serbia · Not yet recruiting

  • 822 Oncology Institute of Vojvodina

    Kamenitz, Serbia · Not yet recruiting

  • 823 Oncology Department, Health Center Kladovo

    Kladovo, Serbia · Not yet recruiting

  • 824 Univ Clin Centre Kragujevac, Dept of Oncology

    Kragujevac, Serbia · Not yet recruiting

  • Site 867

    Banská Bystrica, Slovakia · Not yet recruiting

  • Site 865

    Košice, Slovakia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.